Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Endocrinology

Understanding Your Diagnosis: Multinodular Goiter

At a Glance

Multinodular goiter means the thyroid is enlarged and contains several nodules; most are benign. Doctors use thyroid hormone tests and ultrasound, with scans or needle biopsy when indicated, to assess hormone activity and cancer risk.

A diagnosis of multinodular goiter (MNG) can feel overwhelming, especially when you hear the word “nodules.” However, it is a very common condition, and for most people, it does not mean they have cancer [1][2]. A goiter is simply an enlarged thyroid gland, and “multinodular” means that instead of one smooth lump, the gland has developed several distinct lumps or nodules [3].

It is important to understand that having multiple nodules does not multiply your risk of cancer. In fact, research suggests that the risk of cancer in a multinodular goiter is generally the same as the risk in a person who has only a single thyroid nodule [4][5]. Your doctor will evaluate the individual features of each nodule rather than just counting how many you have.

Why Your Thyroid Gland Changes

The thyroid is a small, butterfly-shaped gland in your neck that produces hormones to control your metabolism. A multinodular goiter develops when the cells in your thyroid grow unevenly over time [6]. This process is often slow and can be caused by several factors:

  • Iodine Levels: In many parts of the world, a lack of iodine in the diet is a primary cause. Without enough iodine, the thyroid cannot make enough hormone, leading the brain to release more TSH (Thyroid-Stimulating Hormone). This hormone pushes the thyroid to work harder, which can cause it to grow and form nodules [6][7]. Note that in areas where iodine is added to salt, deficiency is less common. Do not start taking iodine supplements without consulting your doctor, as too much iodine can also disturb thyroid function [8].
  • Genetics: If your parents or siblings had goiters or nodules, you may be more likely to develop them due to inherited genetic patterns [9][10].
  • Aging and Environmental Factors: Over decades, the thyroid is exposed to natural cellular changes. These age-related changes can trigger certain clusters of thyroid cells to grow faster than others, eventually forming nodules [11][8].

“Toxic” vs. “Nontoxic” Goiters

Doctors categorize multinodular goiters based on how they affect your hormone levels. This distinction is one of the most important parts of your diagnosis:

  • Nontoxic Multinodular Goiter: This is the most common type. In this case, the nodules are “quiet.” Your thyroid gland is enlarged, but it is not producing excess hormones, so your levels (like TSH and T4) remain largely normal [3][12]. The primary concerns are usually the physical size of the goiter and whether it causes discomfort.
  • Toxic Multinodular Goiter: This occurs when one or more of the nodules start acting independently of the brain’s signals. These “autonomous” nodules produce extra thyroid hormone on their own, leading to hyperthyroidism (an overactive thyroid) [13][3]. This can lead to symptoms like a racing heart, weight loss, or anxiety [14].

Are the Nodules Benign?

The vast majority of multinodular goiters are benign (non-cancerous) [2]. While the risk of cancer is not zero, your medical team uses specific tools to carefully determine which nodules—if any—need a closer look:

  1. TSH Blood Test: This is the first step to see if your goiter is toxic or nontoxic [15].
  2. Ultrasound: This imaging tool allows doctors to look at the “personality” of each nodule. They look for features like solid versus fluid-filled (cystic) composition, clear margins, and the presence of tiny calcium spots called microcalcifications [16][17].
  3. Thyroid Scan (Scintigraphy): If your TSH is low (suggesting a toxic goiter), you may have a scan to identify “hot” nodules. Hot nodules are those producing extra hormone; these are almost always benign and rarely require a biopsy unless they have highly suspicious features on an ultrasound or are accompanied by separate nonfunctioning nodules [18][19].
  4. Fine-Needle Aspiration (FNA): If a nodule looks suspicious on ultrasound, your doctor may recommend a biopsy. The size threshold for a biopsy depends entirely on the nodule’s risk level—high-risk nodules might be biopsied at 1 cm, while low-risk nodules might not be biopsied unless they are larger [15][16].

By focusing on the most suspicious nodules rather than every single bump, your care team can provide a clear picture of your health without unnecessary procedures [15]. For many people with MNG, the plan is simply “active surveillance”—monitoring the nodules with regular ultrasounds to ensure they aren’t changing significantly over time [16][20].

Common questions in this guide

What is multinodular goiter, and does it mean I have thyroid cancer?
Multinodular goiter is an enlarged thyroid gland with several nodules. Most multinodular goiters are benign, and having several nodules does not by itself raise cancer risk compared with having one nodule; ultrasound features help determine which nodules need further evaluation.
How is a toxic multinodular goiter different from a nontoxic one?
In a nontoxic multinodular goiter, the thyroid usually makes a normal amount of hormone. In a toxic multinodular goiter, one or more nodules produce thyroid hormone independently, which can cause an overactive thyroid with symptoms such as a racing heart, weight loss, or anxiety.
What tests are usually used to check a multinodular goiter?
A TSH blood test helps show whether the thyroid is making too much hormone, and an ultrasound evaluates the features of each nodule. If TSH is low, a thyroid scan may identify hormone-producing hot nodules; a suspicious nodule may need a fine-needle aspiration biopsy.
Will every nodule in a multinodular goiter need a biopsy?
No. The decision depends on each nodule’s ultrasound appearance and size, so higher-risk nodules may be biopsied at a smaller size while lower-risk nodules may only be monitored. Hot nodules are usually benign and often do not need biopsy unless other concerning findings are present.
Can low iodine cause a multinodular goiter?
Low iodine intake can increase the thyroid-stimulating hormone signal and encourage the thyroid to enlarge and form nodules. Do not start iodine supplements without medical advice, because too much iodine can also disrupt thyroid function.
Can multinodular goiter be watched instead of treated right away?
Yes, many people with multinodular goiter are managed with active surveillance when the nodules do not cause significant symptoms or show concerning features. Follow-up usually includes repeat thyroid ultrasounds, with additional testing if a nodule changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Which specific nodules in my goiter were used to determine my diagnosis, and what are their individual risk levels based on ultrasound findings?
  2. 2.Is my multinodular goiter 'toxic' or 'nontoxic,' and how does that affect the next steps for my treatment or monitoring?
  3. 3.Based on my TSH levels and ultrasound, do I need a thyroid scan to check for 'hot' or 'cold' nodules?
  4. 4.How does the number of nodules I have affect my overall risk compared to someone with just one nodule?
  5. 5.What criteria will you use to decide if a biopsy (fine-needle aspiration) is necessary for any of these nodules?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (20)
  1. 1

    Prevalence and Distribution of Goiter Among Commercially Insured, Working-Age Adults in the United States.

    Tobias J, Krongold J, Kaylan K, et al.

    Thyroid : official journal of the American Thyroid Association 2026; (36(9)):1026-1030 doi:10.1177/10507256261470301.

    PMID: 42473852
  2. 2

    Should the Prevalence of Incidental Thyroid Cancer Determine the Extent of Surgery in Multinodular Goiter?

    Kaliszewski K, Strutyńska-Karpińska M, Zubkiewicz-Kucharska A, et al.

    PloS one 2016; (11(12)):e0168654 doi:10.1371/journal.pone.0168654.

    PMID: 28005977
  3. 3

    Non-Toxic Multinodular Goiter: From Etiopathogenesis to Treatment.

    Unlu MT, Kostek M, Aygun N, et al.

    Sisli Etfal Hastanesi tip bulteni 2022; (56(1)):21-40 doi:10.14744/SEMB.2022.56514.

    PMID: 35515961
  4. 4

    Solitary and multiple thyroid nodules as predictors of malignancy: a systematic review and meta-analysis.

    Rehman AU, Ehsan M, Javed H, et al.

    Thyroid research 2022; (15(1)):22 doi:10.1186/s13044-022-00140-6.

    PMID: 36464691
  5. 5

    Patient outcomes following surgical management of multinodular goiter: Does multinodularity increase the risk of thyroid malignancy?

    Lin YS, Wu HY, Yu MC, et al.

    Medicine 2016; (95(28)):e4194 doi:10.1097/MD.0000000000004194.

    PMID: 27428220
  6. 6

    Review of Factors Contributing to Nodular Goiter and Thyroid Carcinoma.

    Yildirim Simsir I, Cetinkalp S, Kabalak T

    Medical principles and practice : international journal of the Kuwait University, Health Science Centre 2020; (29(1)):1-5 doi:10.1159/000503575.

    PMID: 31542786
  7. 7

    Low Iodine in the Follicular Lumen Caused by Cytoplasm Mis-localization of Sodium Iodide Symporter may Induce Nodular Goiter.

    Huang H, Shi Y, Liang B, et al.

    Biological trace element research 2017; (179(2)):165-171 doi:10.1007/s12011-017-0960-z.

    PMID: 28190186
  8. 8

    Etiopathology, clinical features, and treatment of diffuse and multinodular nontoxic goiters.

    Knobel M

    Journal of endocrinological investigation 2016; (39(4)):357-73 doi:10.1007/s40618-015-0391-7.

    PMID: 26392367
  9. 9

    Nodule-Specific NRF2-Targeted Upregulation in Patients With KEAP1 Mutations and Familial Nontoxic Multinodular Goiter.

    Nishihara E, Fukata S, Hirokawa M, et al.

    The Journal of clinical endocrinology and metabolism 2025; (110(4)):973-982 doi:10.1210/clinem/dgae699.

    PMID: 39373520
  10. 10

    Clinical and genetic features of a family with multinodular goiter harboring a DICER1 c.2035 A >G variant.

    Guo ML, Hu X, Zhu H, et al.

    Thyroid research 2025; (18(1)):34 doi:10.1186/s13044-025-00253-8.

    PMID: 40624559
  11. 11

    Unraveling the Origins of Thyroid Nodules: Inflammation, Hormones, Toxins, and Micronutrient Interactions.

    Mazza AD

    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2026; (58(4)):136-144 doi:10.1055/a-2826-9576.

    PMID: 41776945
  12. 12

    Hyperthyroidism.

    Chaker L, Cooper DS, Walsh JP, Peeters RP

    Lancet (London, England) 2024; (403(10428)):768-780 doi:10.1016/S0140-6736(23)02016-0.

    PMID: 38278171
  13. 13

    The Role of Nuclear Medicine in the Clinical Management of Benign Thyroid Disorders, Part 1: Hyperthyroidism.

    Mariani G, Tonacchera M, Grosso M, et al.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2021; (62(3)):304-312 doi:10.2967/jnumed.120.243170.

    PMID: 33008929
  14. 14

    Tracheomalacia following a total thyroidectomy in a patient with a large non-toxic goiter: A case report.

    Soewoto W, Ardianti M

    International journal of surgery case reports 2024; (116()):109211 doi:10.1016/j.ijscr.2023.109211.

    PMID: 38310789
  15. 15

    2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

    Haugen BR, Alexander EK, Bible KC, et al.

    Thyroid : official journal of the American Thyroid Association 2016; (26(1)):1-133 doi:10.1089/thy.2015.0020.

    PMID: 26462967
  16. 16

    AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ASSOCIAZIONE MEDICI ENDOCRINOLOGI MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE DIAGNOSIS AND MANAGEMENT OF THYROID NODULES--2016 UPDATE.

    Gharib H, Papini E, Garber JR, et al.

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2016; (22(5)):622-39 doi:10.4158/EP161208.GL.

    PMID: 27167915
  17. 17

    Predictive Value of Malignancy of Thyroid Nodule Ultrasound Classification Systems: A Prospective Study.

    Persichetti A, Di Stasio E, Guglielmi R, et al.

    The Journal of clinical endocrinology and metabolism 2018; (103(4)):1359-1368 doi:10.1210/jc.2017-01708.

    PMID: 29408952
  18. 18

    Thyroid Nodules: Advances in Evaluation and Management.

    Kant R, Davis A, Verma V

    American family physician 2020; (102(5)):298-304.

    PMID: 32866364
  19. 19

    Malignancy risk of hyperfunctioning thyroid nodules compared with non-toxic nodules: systematic review and a meta-analysis.

    Lau LW, Ghaznavi S, Frolkis AD, et al.

    Thyroid research 2021; (14(1)):3 doi:10.1186/s13044-021-00094-1.

    PMID: 33632297
  20. 20

    Current Evaluation of Thyroid Nodules.

    Holt EH

    The Medical clinics of North America 2021; (105(6)):1017-1031 doi:10.1016/j.mcna.2021.06.006.

    PMID: 34688412

This page about multinodular goiter is for informational purposes only and does not constitute medical advice. Your clinician should interpret your thyroid tests and ultrasound and recommend appropriate monitoring or biopsy.

Get notified when new evidence is published on multinodular goiter.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.